Octagon Capital Advisors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-100,000
| Closed | -$105K | – | 57 |
|
|
2023
Q4 | $105K | Buy |
+100,000
| New | +$105K | 0.02% | 33 |
|
|
2023
Q2 | – | Sell |
-577,000
| Closed | -$4.67M | – | 41 |
|
|
2023
Q1 | $4.67M | Buy |
+577,000
| New | +$4.67M | 0.67% | 26 |
|
|
2021
Q1 | – | Sell |
-350,000
| Closed | -$2.27M | – | 29 |
|
|
2020
Q4 | $2.27M | Buy |
+350,000
| New | +$2.27M | 0.79% | 29 |
|